Effects of Varenicline on Brain Activity During Nicotine Abstinence

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Nicotine Dependence
Interventions
DRUG

Varenicline

Day 1 - Day 3 0.5mg once daily Day 4 - Day 7 0.5mg twice daily Day 8 - Day 13 1.0mg twice daily

DRUG

Placebo

Participants will take placebo pills for 13 days using the same regimen as the varenicline study period.

Trial Locations (1)

19104

Tobacco Use Research Center, Philadelphia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Pennsylvania

OTHER

NCT00602927 - Effects of Varenicline on Brain Activity During Nicotine Abstinence | Biotech Hunter | Biotech Hunter